Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2016 / Cilt: 50 - Sayı: 2

Disease severity scoring systems in dermatology

Dermatolojide hastalık şiddeti skorlama sistemleri

Pages
42–53
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Disease severity scoring methods are ever more extensively used in the field of dermatology for clinical practice to form an opinion about the prognosis by determining the disease severity; to decide on the most suitable treatment modality for the patient; to evaluate the efficacy of the applied medication; and to compare the efficiency of different treatment methods in clinical studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Scoring systems have been developed to interpret the disease severity objectively by evaluating the parameters of the disease.
📊
Key Findings & Data:Body surface area, visual analogue scale, and physician global assessment are the most frequently used scoring systems for evaluating the clinical severity of the dermatological diseases.
💡
Conclusion & Impact:Disease severity scoring methods are ever more extensively used in the field of dermatology for clinical practice to form an opinion about the prognosis by determining the disease severity; to decide on the most suitable treatment modality for the patient; to evaluate the efficacy of the applied medication; and to compare the efficiency of different treatment methods in clinical studies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Scoring systems have been developed to interpret the disease severity objectively by evaluating the parameters of the disease. Body surface area, visual analogue scale, and physician global assessment are the most frequently used scoring systems for evaluating the clinical severity of the dermatological diseases. Apart from these scoring systems, many specific scoring systems for many dermatological diseases, including acne (acne vulgaris, acne scars), alopecia (androgenetic alopecia, tractional alopecia), bullous diseases (autoimmune bullous diseases, toxic epidermal necrolysis), dermatitis (atopic dermatitis, contact dermatitis, dyshidrotic eczema), hidradenitis suppurativa, hirsutismus, connective tissue diseases (dermatomyositis, skin involvement of systemic lupus erythematosus (LE), discoid LE, scleroderma), lichen planoplaris, mastocytosis, melanocytic lesions, melasma, onychomycosis, oral lichen planus, pityriasis rosea, psoriasis (psoriasis vulgaris, psoriatic arthritis, nail psoriasis), sarcoidosis, urticaria, and vitiligo, have also been developed. Disease severity scoring methods are ever more extensively used in the field of dermatology for clinical practice to form an opinion about the prognosis by determining the disease severity; to decide on the most suitable treatment modality for the patient; to evaluate the efficacy of the applied medication; and to compare the efficiency of different treatment methods in clinical studies.

Özet

Skorlama sistemleri, hastalığa ait parametrelerin değerlendirilerek hastanın klinik şiddetini objektif olarak saptama amacıyla geliştirilmiş olan ölçeklerdir. Vücut yüzey alanı, görsel analog skala ve doktor global değerlendirme skoru dermatolojik hastalıkların klinik şiddetinin değerlendirilmesi amacıyla en sık kullanılan genel skorlama sistemleridir. Bu skorlama sistemleri dışında akne (akne vulgaris, akne skarları), alopesi (androgenetik alopesi, traksiyonel alopesi), Behçet hastalığı, büllöz hastalıklar (otoimmün büllöz hastalıklar, toksik epidermal nekroliz, epidermolizis bülloza), dermatit (atopik dermatit, kontakt dermatit, dishidrotik egzama), hidradenitis suppurativa, hirsutismus, konnektif doku hastalıkları (dermatomyozit, sistemik lupus eritematozusun (LE) deri tutulumu, diskoid LE, skleroderma), liken planopilaris, mastositoz, melanositik lezyonlar-melanom, melazma, mikozis fungoides/Sezary sendromu, onikomikoz, oral liken planus, pitiriyazis rozea, psoriasis (psoriasis vulgaris, psoriatik artrit, tırnak psoriasisi), sarkoidoz, ürtiker ve anjiyoödem ve vitiligo gibi çok sayıda dermatolojik hastalık için spesifik skorlama sistemleri de geliştirilmiştir. Hastalık şiddet skorlama yöntemleri, dermatoloji alanında klinik pratikte hastalığın şiddetinin belirlenerek prognoz hakkında fikir sahibi olunabilmesi, hasta için uygun tedavinin belirlenmesi, uygulanan tedavinin etkinliğinin değerlendirilmesi, klinik araştırmalarda ise farklı tedavi yöntemlerinin etkinliklerinin karşılaştırılabilmesi gibi amaçlarla giderek daha yaygın olarak kullanılmaktadır.

🔖

Cite This Article

ÖZTÜRKCAN, S., ŞAHİN, M. T., BİLAÇ, C. (2022). Disease severity scoring systems in dermatology. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 50 - Sayı: 2, 42–53. https://ajindex.com/articles/621736

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Burke BM, Cunliffe WJ: The assessment of acne vulgaris-the Leeds technique. Br J Dermatol 1984;111:83-92.
  2. Cook CH, Centner RL, Michaels SE: An acne grading method using photographic standards. Arch Dermatol 1979;115:571-5.
  3. Lucchina LC, Kollias N, Phillips SB: Quantitative evaluation of noninflammatory acne with fluorescence photography. Invest Dermatol 1994;102:560. Goodman GJ, Baron JA: Postacne scarring: A qualitative global scarring grading system. Dermatol Surg 2006;32:1458-66.
  4. Dreno B, Khammari A, Orain N, et al: ECCA grading scale: An original validated acne scar grading scale for clinical practice in dermatology. Dermatology 2007;214:46-51.
  5. Van Neste D, Leroy T, Sandraps E: Validation and clinical relevance of a novel scalp coverage scoring method. Skin Res Technol 2003;9:64-72. Ludwig E: Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977;97:247-54.
  6. Chamberlain AJ, Dawber RP: Methods of evaluating hair growth. Australas J Dermatol 2003;44:10-8. Savin RC: A method for visually describing and quantitating hair loss in male pattern baldness. J Invest Dermatol 1995;104:659. Yip L, Sinclair RD: Antiandrogen therapy for androgenetic alopecia. Exp Rev Dermatol 2006;1:261-9.
  7. Dinh QQ, Sinclair R: Female pattern hair loss: Current treatment concepts. Clin Interv Aging 2007;2:189-99.
  8. Olsen EA, Hordinsky MK, Price VH, et al: Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation. J Am Acad Dermatol 2004;51:440-7.
  9. Khumalo NP, Ngwanya RM, Jessop S, Gumedze F, Ehrlich R: Marginal traction alopecia severity score: Development and test of reliability. J Cosmet Dermatol 2007;6:262-9.
  10. Yazici H, Tüzün Y, Pazarli H, et al: Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 1984;43:783-9.
  11. Krause I, Mader R, Sulkes J, et al: Behcet's disease in Israel: the influence of ethnic origin on disease expression and severity. J Rheumatol 2001;28:1033- 6. Davatchi F, Akbaran M, Shahram F, et al: Iran Behçet's disease dynamic activity measure. abstracts of the XIIth european congress of rheumatology. Hung Rheumatol (Suppl):1991;32:10-100.
  12. Kurokawa MS, Suzuki N: Behcet's disease. Clin Exp Med 2004;3:10-20.
  13. Yosipovitch G, Shohat B, Bshara J, et al: Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: Correlations with disease activity and severity. Isr J M